ISRCTN15169616进行中（未招募）Unknown
Improving tuberculosis (TB) patients’ treatment adherence via optimized electronic monitors in China: a pragmatic parallel cluster-randomized trial
ational Natural Science Foundation of China0 个研究点目标入组 300 人开始时间: 2023年7月29日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. The study sample will consist of patients who have been diagnosed in the TB dispensary following national and international care guidelines and who are beginning a typical 6-month short course of chemotherapy in community health centers or township hospitals.
- •2. TB patients must satisfy the following requirements to be considered eligible:
- •2.1. Aged 15 years or over
- •2.2. No speech, mental, visual, auditory, or other communication impairments
- •2.3. No family member residing in the same household who has already been enrolled in the trial
排除标准
- •1. Patients’ age is less than 15 years old
- •2. Have communication impairments, such as speech, mental, visual, auditory, etc
- •3. Having any family member residing in the same household who has already been enrolled in the trial
研究者
相似试验
已完成
不适用
Improving tuberculosis treatment by high-energy biscuits in Mwanza, TanzaniaTuberculosis with and without HIV co-infectionInfections and InfestationsRespiratory tuberculosis, bacteriologically and histologically confirmedISRCTN16552219niversity of Copenhagen (Denmark)100
进行中（未招募）
不适用
PREVENT TB: Improving determinants of TB cure, prevention & diagnosisTuberculosisISRCTN17820976Imperial College London2,336
已完成
4 期
Investigation of a Novel Approach to Improve Treatment Success Rates for Tuberculosis Patients in SenegalTuberculosisNCT00412009Institut de Recherche pour le Developpement1,500
已完成
不适用
Impact of GneXpert MTB/RIF on TB outcomes in an ART clinicHIV/AIDSTuberculosisPACTR201303000505764Professor Peter Mason400
招募中
2 期
The tuberculosis treatments by anti-tuberculosis dry powder prepared as nano-particulate system for inhaling into the respiratory systempatient with pulmonary tuberculosispulmonary tuberculosis treatment,dry powder inhalerTCTR20190404002Government Pharmaceutical Organization (GPO)208